GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction design and rationale for the functional impact of GLP-1 for heart failure treatment study

Kenneth B. Margulies, Kevin J. Anstrom, Adrian F. Hernandez, Margaret M. Redfield, Monica R. Shah, Eugene Braunwald, Thomas P. Cappola

Research output: Contribution to journalArticlepeer-review

29 Scopus citations
Original languageEnglish (US)
Pages (from-to)673-679
Number of pages7
JournalCirculation: Heart Failure
Issue number4
StatePublished - Jul 1 2014


  • Clinical trial
  • Glucagon-like peptide-1
  • Heart failure
  • Insulin resistance

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this